Circular Single-Stranded DNA Enables Efficient...
CMN Interview
Dec. 11, 2024
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Full Circles Therapeutics
Company Type: Therapeutic development
Main focus: Developing novel non-viral gene-editing therapeutics
Company stage: Pre-clinical
Diseases: Autoimmune disorders, genetic diseases, and cancer
Genome-editing tool: CRISPR-Cas9
Funding stage: Venture - Series unknown
Location: Cambridge, Massachusetts, USA
Website: www.fullcirclestx.com
Pipeline:
Partners:
Full Circles Therapeutics is a biotechnology company dedicated to advancing and optimising non-viral gene-editing platforms. The company focuses on driving progress in genomic medicine through its proprietary nuclease editors and viral-free gene-editing technologies. Their platforms, including the enGager system, enable large transgene knock-ins of up to 20 kb, offering safer and more efficient delivery options.
